The Gambia has suspended all paracetamol syrups sales and imports in to the country until a study determines if the medicines are evoking the deaths of children.
Mustapha Bittaye, the countrys health service director, said autopsies conducted on a large number of children beneath the age of five who’ve died in the last 90 days suggest the chance for paracetamol. The deaths have followed kidney injuries in children who took paracetamol syrups to take care of fevers, leading doctors to suspect a primary link.
Counterfeit drugs certainly are a west African problem
A blanket ban on all paracetamol in the united kingdom seeks to tackle the issue at source, to recognize any incidence of low quality or outright counterfeit syrups flooding the united states. That could not be considered a problem unique to the Gambia as west Africa continues a long-running fight to get rid of a higher prevalence of drug counterfeiting.
Around the world, 4 in 10 seized counterfeit drugs come in Africa and in regards to a third of medicines sold in a few elements of Africa are fake, per the US Office on Drug and Crime (UNODC). The counterfeiting menace has affected from oral medications to meningitis vaccines in Niger.
A few of the issues connected with drug counterfeiting in Africa are the proven fact that fake drugs are inexpensive to buy, many types of drugs can be purchased over-the-counter with out a prescription, andalso there’s the issue consumers have in spotting and purchasing original products. Innovative health tech startups are starting to provide some answers to this effect, even though the majority of the early players remain building roots and fine tuning sustainable business models in Nigeria and Ghana.
In the Gambia, poor healthcare delivery is complicated by way of a poverty rate above 40%. The federal government has received over $100 million in World Bank grants since 2020 to boost sustainable care, but email address details are yet to complement expectations going by the data of the suspected paracetamol deaths.